Does Dr. SHELBY HOLLOMAN have financial conflicts of interest?

Dr. SHELBY HOLLOMAN (MD) has received a total of $694 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $694 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. SHELBY HOLLOMAN?

According to CMS Open Payments data, Dr. SHELBY HOLLOMAN received funding from HOLOGIC SALES AND SERVICE ($152), BAYER HEALTHCARE PHARMACEUTICALS ($122), and EXELTIS, USA ($75).

Does Dr. SHELBY HOLLOMAN receive research grants or speaking fees?

Dr. SHELBY HOLLOMAN has received $694 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. SHELBY HOLLOMAN

MDReal-Time Hydrated

Specialty: Advanced Practice Midwife

Practice Location: OREGON, OH 43616

NPI Number: 1639652548

LIFETIME INDUSTRY VALUE

$694

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. HOLLOMAN is a verified Advanced Practice Midwife practitioner based in OREGON, OH.

Between 2021 and 2025, Dr. HOLLOMAN had an overall industry promotional and research financial footprint of $694 as recorded in the federal CMS Open Payments database.

$694 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. HOLLOMAN's primary funding source is HOLOGIC SALES AND SERVICE, which accounts for $152 (representing 21.9% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

HOLOGIC SALES AND SERVICE

Rank 1

$152

21.9%

BAYER HEALTHCARE PHARMACEUTICALS

Rank 2

$122

17.5%

EXELTIS, USA

Rank 3

$75

10.8%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.